Compare Charlie Hospital Semarang Tbk. (RSCH) vs Semen Indonesia (Persero) Tbk. (SMGR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charlie Hospital Semarang Tbk. vs Semen Indonesia (Persero) Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp310 (market cap 821.5B), while Semen Indonesia (Persero) Tbk. trades at Rp1,510 (market cap 10.19T). The key difference: Semen Indonesia (Persero) Tbk. is far larger — about 12.4× Charlie Hospital Semarang Tbk.'s market cap. Which is the better fit depends on your goals.
| RSCH | SMGR | |
|---|---|---|
Market Cap | 821.5B | 10.19T |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charlie Hospital Semarang Tbk.
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →About Semen Indonesia (Persero) Tbk.
PT Semen Indonesia (Persero) Tbk was established on March 25,1953 as NV Pabrik Semen Gresik. On April 17, 1961,NV Pabrik Semen Gresik was transformed into a state enterprise (Persero) by Government Regulation No. 132 year 1961, and subsequently became PT Semen Gresik (Persero). Semen Gresik is a cement producer which was formerly fully owned by the government. On July 1995 the company shareholders meeting agreed to acquired 100% share of two state owned cement producer companies, namely PT. Semen Tonasa and PT. Semen Padang.
Read more on SMGR →
